Literature DB >> 23974500

When ethics precludes randomization: put prospective, matched-pair observational studies to work.

Charles Joseph Kowalski.   

Abstract

Randomized, controlled clinical trials (RCTs) may be possible, permissible, and practical in certain circumstances, but ethical or practical considerations often preclude their utilization. In many such cases, ethical objections will not apply to a similarly oriented, prospective, matched-pair observational study. Additionally, if the methodological rigor associated with the RCT is maintained, potential epistemic losses due to eliminating randomization will be mitigated. It is therefore suggested that when ethics precludes randomization, prospective, protocol-driven, matched-pair observational studies be put to work. One can also envision extending observational studies beyond their traditional time-dependent bounds to encompass never-ending activities focused on the accumulation of clinical knowledge in real-world settings.

Mesh:

Year:  2013        PMID: 23974500     DOI: 10.1353/pbm.2013.0014

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


  2 in total

1.  Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID).

Authors:  Luis Corral-Gudino; Alberto Bahamonde; Francisco Arnaiz-Revillas; Julia Gómez-Barquero; Jesica Abadía-Otero; Carmen García-Ibarbia; Víctor Mora; Ana Cerezo-Hernández; José L Hernández; Graciela López-Muñíz; Fernando Hernández-Blanco; Jose M Cifrián; Jose M Olmos; Miguel Carrascosa; Luis Nieto; María Carmen Fariñas; José A Riancho
Journal:  Wien Klin Wochenschr       Date:  2021-02-03       Impact factor: 1.704

2.  "You can't always get what you want": from doctrine to practicability of study designs for clinical investigation in endometriosis.

Authors:  Paolo Vercellini; Edgardo Somigliana; Ivan Cortinovis; Benedetta Bracco; Lucrezia de Braud; Dhouha Dridi; Silvano Milani
Journal:  BMC Womens Health       Date:  2015-10-22       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.